Latest immunotherapy news
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
posted August 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
posted August 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Monthly Specialist Briefings
Stay Connected
